C-Rad AB (CRAD.B) Stock Overview

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. Its products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise of StaticPhantom, a set-up used to visually verify the precision of the alignment of lasers; Catalyst PT, a real-time tracking solution for particle therapy; cAccessory, which automates the registration and validation of treatment accessories; cAutoVerify, a automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking, and Visual Coaching Solutions used for prospective and retrospective radiotherapy. In addition, it offers support and training services. The company was incorporated in 2004 and is headquartered in Uppsala, Sweden.